Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08FAC
|
|||
| Former ID |
DIB015846
|
|||
| Drug Name |
CaCP-29
|
|||
| Indication | Sepsis [ICD-11: 1G40-1G41; ICD-9: 995.91] | Phase 2 | [1] | |
| Company |
InflaRx GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02246595) Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.